The Hidden Risk in Performance Reporting: Data Integrity Is Becoming the New Compliance Priority

Healthcare leaders today are operating in an environment where performance expectations are rising faster than the systems used to support them. Whether it is HEDIS, UDS, MIPS, or payer-driven quality programs, organizations are under increasing pressure to demonstrate strong outcomes while simultaneously defending the accuracy of the data behind those outcomes. For many executives and operational leaders, the challenge is no longer just improving scores—it is ensuring those scores will hold up under scrutiny when payers, regulators, or auditors begin asking how the results were actually produced.

That shift is driving a quiet but significant change across healthcare compliance: data integrity is becoming just as important as performance itself.

Performance reporting has traditionally focused on outcomes such as measure rates, compliance percentages, and benchmark achievement. However, regulators and payers are increasingly focused on something more foundational—whether submitted data is complete, accurate, and traceable back to its source. HRSA continues to emphasize accuracy, timeliness, and completeness in UDS reporting, while CMS quality programs maintain strict expectations around consistency and reproducibility. The question has evolved from “What did you report?” to “Can you prove how you got there?”

Despite this evolution, many organizations still operate with a primary focus on end results rather than the integrity of the underlying data. This creates a hidden exposure: performance reports that appear strong on the surface but may not withstand validation when the underlying data is reviewed in detail.

In practice, this gap is often driven by operational inconsistencies. Incorrect denominator logic can distort measure calculations. Mapping errors may misclassify key clinical data elements. Missing structured fields limit the ability to accurately capture reportable information. Workflow workarounds—often created to compensate for system limitations—introduce variability that is difficult to monitor or standardize. Over time, differences in documentation practices across providers or departments further weaken the reliability of reported results.

As oversight increases, auditors are looking beyond final outcomes and asking more detailed questions about data lineage. They want to understand how data is generated, how it is validated, and whether results can be consistently reproduced using the same logic and source systems. This level of scrutiny requires organizations to demonstrate not only performance, but also defensible data governance.

For this reason, data validation can no longer be treated as a final checkpoint before submission deadlines. It must become an ongoing operational discipline embedded throughout clinical workflows, coding processes, and reporting cycles. Organizations that rely on retrospective or end-of-cycle reviews often discover issues too late to correct them effectively.

Proactively addressing these risks requires structured review of measure logic, routine evaluation of source data integrity, and consistent validation of workflows well before reporting periods begin. When embedded into day-to-day operations, these practices reduce compliance risk, improve reporting consistency, and strengthen confidence in reported outcomes.

As performance programs continue to evolve, organizations that prioritize data integrity alongside outcomes will be better positioned to meet regulatory expectations and sustain reporting credibility.

For organizations looking to strengthen this foundation, BCA, Inc. offers audit, education, and consulting services designed to evaluate data integrity, identify operational gaps, and support the development of sustainable reporting processes that stand up to increasing scrutiny.

Book your consultation today with one of our experts.